Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes N van den Anker

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Early Human Development|April 9, 2014
How to optimize the evaluation and use of antibiotics in neonatesJohannes N van den Anker
Developmental Disabilities Research Reviews|October 29, 2010
Developmental pharmacologyJohannes N van den Anker
Current Pharmaceutical Design|May 9, 2012
Pharmacokinetics of aminoglycosides in the newbornJohannes N van den Anker, Karel Allegaert
British Journal of Clinical Pharmacology|May 28, 2014
Adverse drug reactions in neonates and infants: a population-tailored approach is neededKarel Allegaert, Johannes N van den Anker
Current Pharmaceutical Design|March 6, 2012
Pharmacokinetics of Aminoglycosides in the NewbornJohannes N van den Anker, Karel Allegaert
Clinical Pharmacokinetics|March 17, 2016
Pediatric Clinical Pharmacology of Voriconazole: Role of Pharmacokinetic/Pharmacodynamic Modeling in PharmacotherapyRajendra S Kadam, Johannes N Van Den Anker
Early Human Development|April 9, 2014
Pharmacologic prevention of perinatal HIV infectionNatella Y Rakhmanina, Johannes N van den Anker
Neonatology|June 29, 2021
Intrauterine Growth Retardation in Pregnant Women with Long QT Syndrome Treated with Beta-Receptor BlockersTatjana Welzel, Birgit Donner, Johannes N van den Anker
Handbook of Experimental Pharmacology|September 2, 2011
Developmental pharmacokineticsJohannes N van den Anker, Matthias Schwab, Gregory L Kearns
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|March 4, 2014
Safety of sildenafil in infants*Samira Samiee-Zafarghandy, P Brian Smith, Johannes N van den Anker
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Early Human Development|April 9, 2014
How to optimize the evaluation and use of antibiotics in neonatesJohannes N van den Anker
Developmental Disabilities Research Reviews|October 29, 2010
Developmental pharmacologyJohannes N van den Anker
Current Pharmaceutical Design|May 9, 2012
Pharmacokinetics of aminoglycosides in the newbornJohannes N van den Anker, Karel Allegaert
British Journal of Clinical Pharmacology|May 28, 2014
Adverse drug reactions in neonates and infants: a population-tailored approach is neededKarel Allegaert, Johannes N van den Anker
Current Pharmaceutical Design|March 6, 2012
Pharmacokinetics of Aminoglycosides in the NewbornJohannes N van den Anker, Karel Allegaert
Clinical Pharmacokinetics|March 17, 2016
Pediatric Clinical Pharmacology of Voriconazole: Role of Pharmacokinetic/Pharmacodynamic Modeling in PharmacotherapyRajendra S Kadam, Johannes N Van Den Anker
Early Human Development|April 9, 2014
Pharmacologic prevention of perinatal HIV infectionNatella Y Rakhmanina, Johannes N van den Anker
Neonatology|June 29, 2021
Intrauterine Growth Retardation in Pregnant Women with Long QT Syndrome Treated with Beta-Receptor BlockersTatjana Welzel, Birgit Donner, Johannes N van den Anker
Handbook of Experimental Pharmacology|September 2, 2011
Developmental pharmacokineticsJohannes N van den Anker, Matthias Schwab, Gregory L Kearns
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|March 4, 2014
Safety of sildenafil in infants*Samira Samiee-Zafarghandy, P Brian Smith, Johannes N van den Anker
Pageof 6